Emerging trends will reshape regional dynamics. North America and Europe are expected to maintain their leadership due to advanced healthcare infrastructure and high demand for innovative antibiotic treatments. Asia Pacific, particularly China and India, will emerge as a high-growth region, driven by a growing patient pool, increasing healthcare expenditure, and a burgeoning generic pharmaceutical industry. The Middle East & Africa region, while still developing, presents significant untapped potential, especially in addressing unmet medical needs related to infectious diseases. South America's market will be influenced by economic conditions and the increasing focus on improving public health infrastructure.  📊 Explore the full report for deeper insights: https://www.archivemarketresearch.com/reports/ampicillin-and-sulbactam-for-injection-347234